Nyhet -

Getinge provides solutions to take cell-based projects further

Medicines and treatments of the future will be developed using the patient’s own cells, to ensure a perfect match every time. In this context, a perfect match refers to the positive way in which the patient’s immune system responds to these tailored medicines, enabling for much more precise and effective treatments to a lot of diseases that are difficult to treat today.

Medical research is moving rapidly. In the wake of the pandemic, research within the area of vaccines and cell therapies is rapidly expanding. The interest has never been greater when it comes to cell and gene manipulation in order to present new treatments to critical illnesses and conditions.

The meaning of the right support

Embarking on a journey towards a successful cell therapy is difficult. It is not done overnight. Life-saving treatments such as vaccines, regenerative medicines and cell and gene therapies take years, sometimes decades, to develop. When Covid-19 hit, there were no decades to spare. The development of the new Covid-19 vaccines was rapid, and this proves that it is possible to do, with the right support.

The number of approved therapies has increased rapidly and there are many projects in discovery stage and some already in clinical trials phase 1. To develop these therapies, different types of cells are used. Getinge bioreactors provide solutions to take those projects further.

What are bioreactors?

A better question is; how do bioreactors work? Essentially, it is a vessel that gives the most suitable environment for the specific type of cell or microorganism to grow.

Getinge provides bioreactors which ensure a closed, sterile environment for these laboratory applications. The bioreactors enable scaling-up the cell growth and an optimization of the bioprocess, which in the end will also be more cost effective for the researcher. In Sweden there are a lot of innovative drug-developing companies, and many on-going and promising are established in the Gothenburg-region, at the new life science hotspot GoCo Health Innovation City.

“We know that there is a lot of knowledge within cell and gene therapies in the Gothenburg-region. We are developing our offer within bioreactors to cater for the needs of both existing and upcoming companies focusing on developing future medicines. With our bioreactors, they get flexibility to their process and help to optimize their cell culture, which is essential to the success of their projects”, says Charlotte Schönbeck, Product Specialist Bioprocess at Getinge.

“We help researchers get closer to their goal of developing fully functional biological medicines tailored to patients’ needs”, she adds.

Relaterade länkar

Ämnen

  • Ekonomi, finans

Kategorier

  • gothenburg life science

Kontakter

Relaterad media

Relaterat innehåll

  • The right place for developing the healthcare of the future

    A world-class innovation city for health is being built right now, close to Gothenburg city centre and therefore easily accessible to companies, researchers, financial institutions and other important stakeholders. GoCo Health Innovation City operates at the forefront of globally renowned research, it brings together the best talents in various disciplines, and it provides facilities for innovatio

  • Swedish medtech innovation to make a difference to women worldwide

    Gedea Biotech has developed the world’s first antibiotic-free treatment, called pHyph, to both treat and prevent bacterial vaginosis. The treatment is clinically proven to be much safer for women to use, as well as providing a lower risk of recurrence. In addition, Gedea aims to prove that pHyph can treat vulvovaginal candidiasis (VVC) as well.

  • SYNLAB Sverige AB sets up one new clinic in Gothenburg and one in Mölndal

    SYNLAB Sverige is a medically accredited laboratory that offers clinical support for companies, healthcare and researchers who need to perform clinical tests of any kind. The range of services is generous, thanks to the expertise gathered within SYNLAB. No test and verification project is too big, SYNLAB can facilitate any project and thus help take it further. Dr Christian Löwbeer is Medical Dir

  • The best place for understanding and treating chronic pain

    Treating pain is one of the most complex and difficult areas of expertise within health care. This is because pain is very individual and experienced differently by each patient. There is no universal cure, no quick-fix treatment to long-term and chronic pain conditions. However, there are some specialists focused solely on treating patients with difficult pain-related conditions.

Fyll i din epostadress för att följa Affärstidningen Näringsliv

När du väljer att skapa ett konto och följa ett nyhetsrum kommer dina personuppgifter behandlas av oss och av ägaren av nyhetsrummet för att du ska kunna motta nyheter och uppdateringar enligt dina bevakningsinställningar.

För att läsa mer om detta, var vänlig läs vår Integritetspolicy som berör vår behandling av dina personuppgifter, och Integritetspolicy för Contacts som berör behandlingen av dina personuppgifter från ägaren av nyhetsrummet du följer.

Vänligen notera att våra Användarvillkor gäller alla våra tjänster.

Du kan dra tillbaka ditt samtycke när som helst genom att avregistrera dig eller genom att ta bort ditt konto.
Kolla din inkorg

Mejl skickat till __email__. Klicka på länken i mejlet för att följa Affärstidningen Näringsliv.

Okej